182 related articles for article (PubMed ID: 7840022)
1. Immunologic evaluation of 24 month course of sublingual immunotherapy.
Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
Tari MG; Mancino M; Monti G
Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
Mungan D; Misirligil Z; Gürbüz L
Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
Tseng SH; Fu LS; Nong BR; Weng JD; Shyur SD
Asian Pac J Allergy Immunol; 2008; 26(2-3):105-12. PubMed ID: 19054928
[TBL] [Abstract][Full Text] [Related]
9. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides.
Marcucci F; Sensi LG; Caffarelli C; Cavagni G; Bernardini R; Tiri A; Riva G; Novembre E
Allergy; 2002 Jan; 57(1):23-8. PubMed ID: 11991284
[TBL] [Abstract][Full Text] [Related]
10. [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract].
Muñoz-López F; Martín Mateos A; Moreira A; Martínez Marín F
Allergol Immunopathol (Madr); 1994; 22(3):132-4. PubMed ID: 7976962
[No Abstract] [Full Text] [Related]
11. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma--a double-blind study.
Tari MG; Mancino M; Monti G
J Investig Allergol Clin Immunol; 1992; 2(2):59-67. PubMed ID: 1342886
[TBL] [Abstract][Full Text] [Related]
13. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
[TBL] [Abstract][Full Text] [Related]
14. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial.
Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F
Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
17. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
18. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
[TBL] [Abstract][Full Text] [Related]
19. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
[TBL] [Abstract][Full Text] [Related]
20. [Rush immunotherapy of perennial allergic rhinitis].
Ito K
Arerugi; 1989 Nov; 38(11):1246-54. PubMed ID: 2627159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
